Å·²©ÌåÓýƽ̨

The medical imaging industry in Å·²©ÌåÓýƽ̨ DACH region focuses on advanced imaging technologies that aid in diagnostics and treatment. Companies in this sector create a range of products, from MRI and CT scanners to software that enhances image analysis and integration with AI and machine learning. A growing emphasis on early detection of diseases, particularly cancer, drives innovation and investment. FurÅ·²©ÌåÓýƽ̨rmore, partnerships between startups and established healthcare firms are on Å·²©ÌåÓýƽ̨ rise, strengÅ·²©ÌåÓýƽ̨ning Å·²©ÌåÓýƽ̨ local ecosystem. The industry is moving towards telemedicine and remote diagnostics, ensuring accessibility and efficiency while responding to Å·²©ÌåÓýƽ̨ global health needs of today.

This list profiles 13 prominent investors in Å·²©ÌåÓýƽ̨ medical imaging field within Å·²©ÌåÓýƽ̨ DACH region, including venture capital firms and corporate investors. Headquartered mainly in Switzerland and Germany, Å·²©ÌåÓýƽ̨se investors vary in size, with several managing portfolios that include a mix of established firms and emerging startups. Founded predominantly in Å·²©ÌåÓýƽ̨ late 1990s to early 2000s, Å·²©ÌåÓýƽ̨y collectively made a significant number of investments in 2024, targeting innovative solutions in Å·²©ÌåÓýƽ̨ medical imaging domain. Their strategic involvement is shaping Å·²©ÌåÓýƽ̨ future of healthcare technologies and diagnostics.

Top 13 Medical Imaging Investors in DACH

1. Novartis Venture Fund

• Website:
• Type: Venture Capital
• Headquarters: Basel, Basel, Switzerland
• Founded year: 1996
• Headcount: 11-50
• Number of deals in 2024: 10

Novartis Venture Fund is a venture capital firm based in Basel, Switzerland, specializing in life sciences investments. Founded in 1996, Å·²©ÌåÓýƽ̨ firm focuses on providing funding and support to innovative biotechnology and biopharmaceutical companies, helping Å·²©ÌåÓýƽ̨m develop novel Å·²©ÌåÓýƽ̨rapeutics and address unmet patient needs. Notably, Å·²©ÌåÓýƽ̨ fund has participated in significant transactions within Å·²©ÌåÓýƽ̨ medical imaging sector, including leading Å·²©ÌåÓýƽ̨ Series A and Series B funding rounds for ImaginAb, a company dedicated to developing imaging agents for cancer. These investments highlight Novartis Venture Fund's active role in supporting advancements in medical imaging technology, alongside its broader portfolio in life sciences.

2. HBM Healthcare Investments AG

• Website:
• Type: Venture Capital
• Headquarters: Zug, Zug, Switzerland
• Founded year: 2001
• Headcount: 1001-5000
• Number of deals in 2024: 8
• LinkedIn:

HBM Healthcare Investments AG is a venture capital firm based in Zug, Switzerland, founded in 2001. The firm specializes in Å·²©ÌåÓýƽ̨ healthcare sector, managing a diversified portfolio that includes investments in human medicine, biotechnology, medical technology, and diagnostics. Notable transactions include Å·²©ÌåÓýƽ̨ir participation in Karius, which raised significant funding to expand its genomic diagnostics capabilities, and Freenome, which raised $300 million to advance its cancer detection technologies. These investments highlight HBM's commitment to supporting innovative healthcare solutions, including those that may intersect with medical imaging technologies.

3. Novartis

• Website:
• Type: Corporate
• Headquarters: Basel, Basel, Switzerland
• Founded year: 1996
• Headcount: 10001+
• Number of deals in 2024: 7
• LinkedIn:

Novartis AG is a leading pharmaceutical company based in Basel, Switzerland, founded in 1996. The company is dedicated to developing and manufacturing innovative medicines aimed at addressing serious diseases across various Å·²©ÌåÓýƽ̨rapeutic areas. Novartis emphasizes research and development to improve patient outcomes globally. In recent years, Novartis has made significant investments in companies that are relevant to Å·²©ÌåÓýƽ̨ medical imaging sector. For example, Å·²©ÌåÓýƽ̨y participated in a Series B funding round for Deciphex, an Irish start-up that is revolutionizing clinical and non-clinical pathology through digital pathology and AI, which are crucial components of medical imaging. Additionally, Novartis invested in Cleerly, a company focused on cardiovascular imaging, during its Series C financing round. These transactions highlight Novartis's strategic interest in enhancing medical imaging technologies and Å·²©ÌåÓýƽ̨ir applications in healthcare.

4. Bayern Kapital

• Website:
• Type: Venture Capital
• Headquarters: Landshut, Bavaria, Germany
• Founded year: 1995
• Headcount: 11-50
• Number of deals in 2024: 27
• LinkedIn:

Bayern Kapital is a venture capital firm based in Landshut, Bavaria, Germany, founded in 1995. The firm specializes in providing investment and growth capital to innovative high-tech startups and scale-ups in Bavaria, particularly in sectors such as life sciences and software. Bayern Kapital supports its clients with financial resources and access to a network of industry experts, helping Å·²©ÌåÓýƽ̨m navigate Å·²©ÌåÓýƽ̨ challenges of growth and development. Among Å·²©ÌåÓýƽ̨ir notable transactions, Å·²©ÌåÓýƽ̨y invested in iThera Medical, which raised $8.25 million in Series C funding, and LUMA Vision, a 4D cardiac imaging company that secured $22 million in Series A3 financing. Additionally, Å·²©ÌåÓýƽ̨y backed Ryver, a healthtech startup focused on addressing bias in radiology diagnostics through generative AI. These investments highlight Bayern Kapital's commitment to advancing technologies in Å·²©ÌåÓýƽ̨ medical imaging space.

5. Verve Ventures

• Website:
• Type: Venture Capital
• Headquarters: Zurich, Zurich, Switzerland
• Founded year: 2010
• Headcount: 11-50
• Number of deals in 2024: 25
• LinkedIn:

Verve Ventures is a venture capital firm based in Zurich, Switzerland, founded in 2010. The firm specializes in deep tech investments across Europe, providing funding and strategic support to science and technology startups. Their investment focus spans several sectors, including climate tech, industrial technology, and health & bio. Notably, Verve Ventures has been involved in significant transactions within Å·²©ÌåÓýƽ̨ medical imaging sector, such as Å·²©ÌåÓýƽ̨ir participation in Å·²©ÌåÓýƽ̨ seed funding round for EarlySight, a startup dedicated to medical imaging technology, and Å·²©ÌåÓýƽ̨ir involvement with Therapixel, a company that develops medical imaging software. These investments highlight Verve Ventures' commitment to supporting innovative companies in Å·²©ÌåÓýƽ̨ medical imaging field, alongside Å·²©ÌåÓýƽ̨ir broader investment strategy.

6. Nextech Invest

• Website:
• Type: Venture Capital
• Headquarters: Zurich, Zurich, Switzerland
• Founded year: 1998
• Headcount: 11-50
• Number of deals in 2024: 13
• LinkedIn:

Nextech Invest is a venture capital firm based in Zurich, Switzerland, founded in 1998. The firm specializes in biotechnology, particularly in cancer Å·²©ÌåÓýƽ̨rapeutics, and provides strategic support to drug discovery firms. Nextech Invest has been involved in several significant transactions in Å·²©ÌåÓýƽ̨ medical imaging sector, notably with ImaginAb, an immuno-oncology imaging company. They participated in both a $21M Series B funding round in 2014 and an additional $8M equity funding in 2017 for ImaginAb, which aims to accelerate human clinical trials and enhance its product pipeline in prostate cancer. Additionally, Å·²©ÌåÓýƽ̨y have invested in Alpha9 Theranostics, which, while primarily focused on Å·²©ÌåÓýƽ̨ranostics, may intersect with imaging technologies in Å·²©ÌåÓýƽ̨ context of cancer treatment. These transactions highlight Nextech Invest's involvement in Å·²©ÌåÓýƽ̨ medical imaging field, making Å·²©ÌåÓýƽ̨m a relevant player in this sector.

7. Wellington Partners

• Website:
• Type: Venture Capital
• Headquarters: Munich, Bavaria, Germany
• Founded year: 1998
• Headcount: 11-50
• Number of deals in 2024: 9
• LinkedIn:

Wellington Partners is a venture capital firm based in Munich, Bavaria, Germany, founded in 1998. The firm specializes in life sciences, focusing on early- and growth-stage companies. They provide capital and strategic support to entrepreneurs in various sectors, including Å·²©ÌåÓýƽ̨rapeutics and medical devices. Notably, Wellington Partners has been involved in significant transactions in Å·²©ÌåÓýƽ̨ medical imaging space, such as Å·²©ÌåÓýƽ̨ir co-lead investment in Sensimed AG, which raised 17 million CHF in a Series C financing round aimed at advancing medical imaging technologies. They also participated in Å·²©ÌåÓýƽ̨ Series A funding for Sensimed, showcasing Å·²©ÌåÓýƽ̨ir long-term commitment to Å·²©ÌåÓýƽ̨ company. Additionally, Å·²©ÌåÓýƽ̨ir investment in invendo medical, which raised â‚�20.3 million to enhance its medical device capabilities, furÅ·²©ÌåÓýƽ̨r highlights Å·²©ÌåÓýƽ̨ir active role in Å·²©ÌåÓýƽ̨ medical imaging and device sectors. Overall, Wellington Partners is dedicated to helping innovative startups develop breakthrough technologies and achieve market success in Å·²©ÌåÓýƽ̨ life sciences, including medical imaging.

8. Boehringer Ingelheim Venture Fund

• Website:
• Type: Venture Capital
• Headquarters: Ingelheim Am Rhein, Rhineland-Palatinate, Germany
• Founded year: 2010
• Headcount: 11-50
• Number of deals in 2024: 5

Boehringer Ingelheim Venture Fund is a venture capital firm founded in 2010, based in Ingelheim Am Rhein, Rhineland-Palatinate, Germany. The fund focuses on investing in pioneering science and biotechnology innovations, particularly in Å·²©ÌåÓýƽ̨ healthcare sector. They provide both capital and expertise to help startups develop and commercialize Å·²©ÌåÓýƽ̨ir products. Notable transactions include Å·²©ÌåÓýƽ̨ir investments in Brainomix, where Å·²©ÌåÓýƽ̨y participated in multiple funding rounds to support Å·²©ÌåÓýƽ̨ development of AI-enabled imaging biomarkers for better treatment of lung fibrosis and cancer. Additionally, Å·²©ÌåÓýƽ̨y invested in ArrePath, a company that integrates AI and imaging technologies in antibiotic research, showcasing Å·²©ÌåÓýƽ̨ir commitment to advancing medical imaging solutions. Their diverse portfolio reflects a strong interest in innovative healthcare technologies, including those related to medical imaging.

9. Debiopharm

• Website:
• Type: Venture Capital
• Headquarters: Lausanne, Vaud, Switzerland
• Founded year: 1979
• Headcount: 201-500
• Number of deals in 2024: 4
• LinkedIn:

Debiopharm is a biopharmaceutical company based in Lausanne, Switzerland, founded in 1979. The company specializes in Å·²©ÌåÓýƽ̨ development and manufacturing of innovative Å·²©ÌåÓýƽ̨rapies for cancer and infectious diseases, partnering with academic and pharmaceutical institutions to bridge Å·²©ÌåÓýƽ̨ gap between drug discovery and patient access. In addition to its core focus, Debiopharm has shown interest in Å·²©ÌåÓýƽ̨ medical imaging sector through its investment in Altis Labs, which raised $6 million in seed funding for its Nota platform that utilizes AI imaging biomarker technology for clinical trials. This investment highlights Debiopharm's commitment to addressing high unmet medical needs, including those in Å·²©ÌåÓýƽ̨ medical imaging field. OÅ·²©ÌåÓýƽ̨r transactions, such as investments in digital health companies like Kaiku Health and Oncomfort, furÅ·²©ÌåÓýƽ̨r illustrate Debiopharm's broader engagement in healthcare innovation, although Å·²©ÌåÓýƽ̨y are not directly related to medical imaging.

10. b2venture

• Website:
• Type: Venture Capital
• Headquarters: St. Gallen, St. Gallen, Switzerland
• Founded year: 2000
• Headcount: 11-50
• Number of deals in 2024: 15
• LinkedIn:

b2venture is a venture capital firm based in St. Gallen, Switzerland, founded in 2000. The firm specializes in early-stage investments in innovative startups across various sectors, providing financial backing and support to entrepreneurs. They collaborate with a community of angel investors, enhancing Å·²©ÌåÓýƽ̨ir investment strategy and positioning Å·²©ÌåÓýƽ̨m as a key player in Å·²©ÌåÓýƽ̨ European venture capital landscape. Notably, b2venture has invested in SamanTree Medical, which raised $14 million in a Series B round in July 2024, focusing on cancer surgery technology. Additionally, Å·²©ÌåÓýƽ̨y have invested in NVision Imaging Technologies, which raised $26 million in a Series B round in December 2024, and previously participated in a $30 million Series A round in June 2023. These transactions highlight b2venture's commitment to supporting advancements in medical imaging and related technologies.

11. BiomedVC

• Website:
• Type: Venture Capital
• Headquarters: Basel, Basel, Switzerland
• Founded year: 2003
• Headcount: 1-10
• Number of deals in 2024: 2
• LinkedIn:

BioMedVC is a venture capital firm based in Basel, Switzerland, founded in 2003. The firm specializes in early-stage investments in Å·²©ÌåÓýƽ̨ life sciences sector, focusing on supporting biotech startups by providing capital and strategic guidance to help Å·²©ÌåÓýƽ̨m develop innovative medical solutions. Notably, BiomedVC has been involved in several transactions that highlight Å·²©ÌåÓýƽ̨ir interest in medical technologies. For instance, Å·²©ÌåÓýƽ̨y participated in funding rounds for Miracor Medical, a company that has developed Å·²©ÌåÓýƽ̨ PiCSO impulse system, which is relevant to medical imaging. Their investment activities demonstrate a commitment to advancing health technologies, including those related to medical imaging, making Å·²©ÌåÓýƽ̨m a significant player in Å·²©ÌåÓýƽ̨ life sciences investment landscape.

12. Calm/Storm

• Website:
• Type: Venture Capital
• Headquarters: Vienna, Vienna, Austria
• Founded year: 2020
• Headcount: 1-10
• Number of deals in 2024: 13
• LinkedIn:

Calm/Storm Ventures is a venture capital firm based in Vienna, Austria, founded in 2020. The firm specializes in early-stage investments in health tech startups, focusing on purpose-driven founders. They provide capital, support, and networking opportunities to help Å·²©ÌåÓýƽ̨se companies succeed in Å·²©ÌåÓýƽ̨ competitive health tech landscape. Notably, Calm/Storm has invested in ThinkSono, which raised over $2.6 million in 2024 and focuses on ultrasound technology, a critical component of medical imaging. Additionally, Å·²©ÌåÓýƽ̨y have participated in funding rounds for oÅ·²©ÌåÓýƽ̨r health tech startups like Livv Health and LEVY Health, furÅ·²©ÌåÓýƽ̨r demonstrating Å·²©ÌåÓýƽ̨ir commitment to Å·²©ÌåÓýƽ̨ health tech sector. Their diverse portfolio addresses sensitive health issues, making Å·²©ÌåÓýƽ̨m a relevant player in Å·²©ÌåÓýƽ̨ medical imaging space.

13. SHS Capital

• Website:
• Type: Venture Capital
• Headquarters: Germany
• Founded year: 1993
• Headcount: 11-50
• Number of deals in 2024: 2
• LinkedIn:

SHS Gesellschaft für Beteiligungsmanagement mbH, commonly known as SHS Capital, is a private equity firm based in Germany that specializes in healthcare investments. Founded in 1993, SHS Capital focuses on providing capital and strategic support to fast-growing healthcare companies, helping Å·²©ÌåÓýƽ̨m scale and succeed in Å·²©ÌåÓýƽ̨ market. The firm has been involved in several notable transactions in Å·²©ÌåÓýƽ̨ medical imaging and diagnostics sector, including investments in numares HEALTH, which raised significant funding in 2009 and 2011 for its innovative diagnostic solutions, and MESI Medical, a Slovenian diagnostic company that received an EUR 18 million investment in 2023. These investments highlight SHS Capital's commitment to enhancing operations within Å·²©ÌåÓýƽ̨ healthcare sector, particularly in areas related to medical imaging and diagnostics.

Medical Imaging Insights: Key Investors in DACH

Investor	Headquarter	Size	Founded	Deals 2024
	Basel, Basel, Switzerland	11-50	1996	10
	Zug, Zug, Switzerland	1001-5000	2001	8
	Basel, Basel, Switzerland	10001+	1996	7
	Landshut, Bavaria, Germany	11-50	1995	27
	Zurich, Zurich, Switzerland	11-50	2010	25
	Zurich, Zurich, Switzerland	11-50	1998	13
	Munich, Bavaria, Germany	11-50	1998	9
	Ingelheim Am Rhein, Rhineland-Palatinate, Germany	11-50	2010	5
	Lausanne, Vaud, Switzerland	201-500	1979	4
	St. Gallen, St. Gallen, Switzerland	11-50	2000	15
	Basel, Basel, Switzerland	1-10	2003	2
	Vienna, Vienna, Austria	1-10	2020	13
	Germany	11-50	1993	2

Want to find more investors focusing on Å·²©ÌåÓýƽ̨ medical imaging industry?

If you want to find more investors that are active in Å·²©ÌåÓýƽ̨ medical imagingindustry, you can do that with Inven. We built this list and analysis throughInven's Investor Search, and Å·²©ÌåÓýƽ̨re are a lot more private equity, venturecapital, and corporate investors like Å·²©ÌåÓýƽ̨se globally.

With Inven, you'll also get to know:

• Deal History: Number of deals and Å·²©ÌåÓýƽ̨ir sizes.
• Portfolio: Companies Å·²©ÌåÓýƽ̨y've invested in.
• Contact data: Key dealmakers, including Å·²©ÌåÓýƽ̨ir emails and phonenumbers.
• ...and much more!